1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA USP17L3 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA SNX4 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA SHROOM2 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA SMC4 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA BMP4 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA RGR CTRPv2 pan-cancer AAC 0.087 0.01
mRNA RBMS3 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA OSR1 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA ARAP2 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA SMCO4 CTRPv2 pan-cancer AAC -0.094 0.01
Download CSV